Improving chemoradiotherapy in rectal cancer

Oncologist

Volumn 6, Issue SUPPL. 4, 2001, Pages 29-34

  Glynne Jones, Robert ^a,c   Debus, Jürgen ^b  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c MOUNT VERNON CANCER CENTRE   (United Kingdom)

Author keywords

5 FU; Capecitabine; Chemoradiotherapy; Radiotherapy; Rectal cancer

Indexed keywords

CAPECITABINE; FLUOROPYRIMIDINE DERIVATIVE; FLUOROURACIL; THYMIDINE PHOSPHORYLASE;

ANTINEOPLASTIC ACTIVITY; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONFERENCE PAPER; ENZYME REGULATION; HUMAN; PREOPERATIVE EVALUATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RECTUM CANCER; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

EID: 0034797783     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: 10.1634/theoncologist.6-suppl_4-29     Document Type: Conference Paper

References (21)

1. Analysis of 830 cases of rectal adenocarcinoma. 1. Progressively improved results of treatment
2. Prolongation of the disease-free interval in surgically treated rectal carcinoma
3. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: Results from NSABP protocol R-01
4. Effective surgical adjuvant therapy for high-risk rectal carcinoma
5. Adjuvant therapy for patients with colon and rectum cancer
6. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery
7. Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum
8. Pre- or postoperative radiotherapy in rectal and rectosigmoid carcinoma. Report from a randomized multicenter trial
9. Radiotherapy in addition to radical surgery in rectal cancer: Evidence for a dose-response effect favoring preoperative treatment
10. Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable cancer
11. Preoperative irradiation affects functional results after surgery for rectal cancer: Results from a randomized study
12. Preoperative radiotherapy for resectable rectal cancer: A meta-analysis
13. Phase III randomized trial of preoperative versus postoperative multimodality therapy in patients with carcinoma of the rectum (NSABP R-03)
14. Rectal carcinoma: Thin-section MR imaging for staging in 28 patients
15. Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery
16. Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue
17. Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients
18. X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (Xeloda) in human cancer xenografts
19. Capecitabine combined with simultaneous radiotherapy in rectal cancer: A phase-I-study
20. Adjuvant therapy of rectal cancer
21. Prospective trial of preoperative concomitant boost radiotherapy with continuous infusion 5-fluorouracil for locally advanced rectal cancer